ANCA associated pulmonary fibrosis: vasculitis or not vasculitis [0.03%]
抗中性粒细胞胞浆抗体相关肺纤维化：是血管炎还是非血管炎？
Helena Codes-Méndez,Diego Castillo,Patricia Moya-Alvarado et al.
Helena Codes-Méndez et al.
Purpose of review: The intersection of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and interstitial lung disease (ILD) represents a complex and increasingly recognized clinical challenge. This r...
Current concepts in the pathogenesis and clinical management of lymphangioleiomyomatosis [0.03%]
淋巴管肌瘤病的发病机制和临床管理概念更新
Donal O&#x;Malley,Nishant Gupta,Cormac McCarthy
Donal O&#x;Malley
Purpose of review: Lymphangioleiomyomatosis (LAM) is a systemic, low-grade, metastasizing neoplasm that predominantly affects women. This review demonstrates recent progression in this rare disease, from improved understa...
Pulmonary veno-occlusive disease: a paradigm of diagnosis and therapeutic challenges in pulmonary hypertension [0.03%]
肺静脉阻塞病：肺动脉高压诊断与治疗挑战的范例
Benoit Aguado,Julien Grynblat,Brandon Budhram et al.
Benoit Aguado et al.
Purpose of review: Pulmonary veno-occlusive disease (PVOD) is a rare and life-threatening form of precapillary pulmonary hypertension. This review aims to outline its genetic and environmental risk factors, highlight key ...
Editorial: Integrating the general pulmonologist in the continuum of lung transplantation: a primer on current issues in referral, selection, and posttransplant care [0.03%]
编辑来稿：肺移植受者全程管理中的内科医师：转诊、选择和移植后治疗相关问题综述
Carli J Lehr,Caroline Patterson
Carli J Lehr
Mark E Snyder,John F McDyer
Mark E Snyder
Purpose of review: Median survival after lung transplantation is 5.7 years, which lags behind other solid organ transplants, such as heart, liver, and kidney. The major barrier to long-term survival in lung transplant rec...
Abhishek Sarkar,Shaikh Muhammad Noor Husnain,Kassem Harris
Abhishek Sarkar
Purpose of review: The purpose of this review is to provide clinicians a comprehensive overview of the epidemiology, clinical symptoms, radiological features, pathological features, and management recommendations for the ...
Considering candidates: modifiable and nonmodifiable risk factors for lung transplantation [0.03%]
供肺移植的供者：可改变和不可改变的风险因素
Julia A Maheshwari,Lorriana E Leard
Julia A Maheshwari
Purpose of review: Evaluation of a candidate's risk profile for lung transplant includes understanding which patient factors can be addressed to minimize transplant risk. Some risk factors can be modified, while others ca...
Artificial intelligence applications for the diagnosis of pulmonary nodules [0.03%]
人工智能在肺结节诊断中的应用研究进展
David E Ost
David E Ost
Purpose of review: This review evaluates the role of artificial intelligence (AI) in diagnosing solitary pulmonary nodules (SPNs), focusing on clinical applications and limitations in pulmonary medicine. It explores AI's ...
Infections and lung transplantation: key considerations for eligibility, management, and posttransplant care [0.03%]
感染与肺移植：关于移植资质、管理和术后护理的关键注意事项
Jonathan Huang,Rachel Friedman-Moraco,Stephanie Pouch
Jonathan Huang
Purpose of review: Lung transplantation is a critical and evolving therapy for patients with end-stage lung disease. As the need for lung transplantation increases, careful candidate selection is vital to maximizing outco...